EichorEICHOR
Condition: Human Immunodeficiency Virus Type 1 Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Human Immunodeficiency Virus Type 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
Phase N/A · 4 location(s) · Euresist Network GEIE · NCT06127290Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
NA · 1 location(s) · University College Dublin · NCT04174755CAR-T Cells for HIV Infection
Phase 1/Phase 2 · 2 location(s) · Steven Deeks · NCT04648046A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297Analyses of Newly Diagnosed HIV Infection in Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07725042Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
Phase 3 · 9 location(s) · University of Nairobi · NCT06747507Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Succes
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT06774872Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
Phase 3 · 3 location(s) · Chelsea and Westminster NHS Foundation Trust · NCT04892654Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Phase 2 · 9 location(s) · Gilead Sciences · NCT06749054Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Pat
Phase N/A · 8 location(s) · Association pour la promotion de la recherche en maladies in · NCT069021422DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
Phase 4 · 1 location(s) · University Hospital, Ghent · NCT04553081Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
Phase N/A · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT06799338Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive An
Phase 4 · 1 location(s) · UBATEC · NCT06967753Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
NA · 2 location(s) · Florida International University · NCT05136703Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatmen
Phase 3 · 2 location(s) · Gilead Sciences · NCT07683000Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-0
Phase 2 · 24 location(s) · Merck Sharp & Dohme LLC · NCT04375800A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involv
Phase 4 · 15 location(s) · Gilead Sciences · NCT06337032Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and
Phase N/A · 1 location(s) · Castagna Antonella · NCT04098315A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT04513626Dasatinib for HIV-1 Reservoir Reduction
Phase 1 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07342491Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
Phase 4 · 2 location(s) · Instituto Mexicano del Seguro Social · NCT06602622Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
Phase 4 · 8 location(s) · Fundacion para la Formacion e Investigacion Sanitarias de la · NCT06646562Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT06554717Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among P
Phase 1/Phase 2 · 1 location(s) · University of Aarhus · NCT05668026
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.